{"ticker": {"uuid": "4fcd095e-49cf-482a-8b8d-9316fd7725cb", "symbol": "PROF", "name": "Profound Medical Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Profound Medical Corp.", "summary": "Profound Medical Corp. announced that its TULSA Procedure\u2122 will be featured in multiple presentations by leading physicians at the upcoming Society of Robotic Surgery Annual Meeting in Fort Lauderdale, FL, from July 23-26. Shares of Profound Medical Corp. (T.PRN) were trading up ", "url": "https://www.baystreet.ca/stocksinplayarticles/47557/Stocks-in-Play-Profound-Medical-Corp", "source_name": "Baystreet.ca", "published_at": "2026-07-15T14:40:35", "published_display": "15 Jul 2026 14:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical to Highlight TULSA Procedure at SRS2026, Multiple Presentations and Investor Session", "summary": "Profound Medical will showcase its MRI-guided, AI-powered TULSA Procedure at the SRS2026 Annual Meeting through multiple expert presentations and an investor session. The event will feature presentations on real-world and trial outcomes, including primary safety results from the ", "url": "https://www.tradingview.com/news/tradingview:5a0ac6d2adcbb:0-profound-medical-to-highlight-tulsa-procedure-at-srs2026-multiple-presentations-and-investor-session/", "source_name": "TradingView", "published_at": "2026-07-15T11:40:35", "published_display": "15 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical's TULSA joins 8-company SRS surgery spotlight", "summary": "Profound Medical's (NASDAQ:PROF) TULSA Procedure will be prominently featured at the Society of Robotic Surgery (SRS) Annual Meeting in Fort Lauderdale, FL, from July 23-26, 2026. The MRI-guided, AI-powered, robotically driven technology will be highlighted in multiple physician-", "url": "https://www.stocktitan.net/news/PROF/profound-medical-autonomous-robotics-and-incisionless-surgery-to-rnj381katrgl.html", "source_name": "Stock Titan", "published_at": "2026-07-15T11:40:35", "published_display": "15 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (NASDAQ: PROF) plans strong TULSA presence at SRS2026", "summary": "Profound Medical Corp. announced a significant presence for its TULSA Procedure at the Society of Robotic Surgery Annual Meeting (SRS2026) from July 23-26, 2026, in Fort Lauderdale, FL. The MRI-guided, AI-powered treatment for prostate cancer will be highlighted in multiple physi", "url": "https://www.stocktitan.net/sec-filings/PROF/8-k-profound-medical-corp-reports-material-event-ba00b4e447b5.html", "source_name": "Stock Titan", "published_at": "2026-07-15T11:40:34", "published_display": "15 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026", "summary": "Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) announced its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure\u2122 will be prominently featured at the Society of Robotic Surgery (SRS) Annual Meeting from July 23-26, 2026. Leading physicians will present on", "url": "https://sg.finance.yahoo.com/news/profound-medical-autonomous-robotics-incisionless-114500643.html", "source_name": "Market source", "published_at": "2026-07-15T11:40:34", "published_display": "15 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Discipline and Rules-Based Execution in PROF Response", "summary": "This article provides an in-depth analysis of Profound Medical Corp. (NASDAQ: PROF), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines distinct institutional trading strategies, including position trading, momentum breakout, and risk hed", "url": "https://news.stocktradersdaily.com/news_release/134/Discipline_and_Rules-Based_Execution_in_PROF_Response_070926115802_1783612682.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-09T12:18:24", "published_display": "09 Jul 2026 12:18", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOMlFhV3NXRWptNTFVc0dXcVNQYkswdG80eF9UU1I5VHdxZ3Ntc1VsS3AxSWJFc3hzMVdYS29LZ0V3djhTMGdHQWZMcDFuQnhyX1VtbUJRM1RoNm9rRHdna0pJOXBDMVRRTUpDOEF0OXhhX3V2Q05QQ25iV3N0ekFKT3ZkN3REOWVtZi1QOVZfZTJGYzBGZnFVVHdB?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp. (PROF) Edges Higher as Support Holds Near $6.50 - Put Dominated", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNNHpBaE9NZkxOdGFsUU1FLThqQURERjVLU19RRk9zOFRDdW1Xblg3bzBIdGVhQWFoTWdoMm02VjA4bGNILWpRUDhyY2xrZ00xRms5SmhFT3R0RzBnWkVBZExqSEYzdG5tc3dibXZxQ0VSa0FiMW1qeThLSFJrSzJSWThRWGVtOU1pZnNRVEpkZmc1aE11V2RZTG8tZlJ2SWtHOWpWSmlScVFIX1E?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-05T22:48:26+00:00", "published_display": "05 Jul 2026 22:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Profound Medical Corp \u2013 TSX:PRN", "summary": "This page provides financial information for Profound Medical Corp (TSX:PRN), specifically focusing on its forward price-to-earnings ratio. It indicates that the market is closed with no recent trades for the company. The page also lists various data providers and copyright infor", "url": "https://www.tradingview.com/symbols/TSX-PRN/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T01:10:41", "published_display": "05 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp. (PROF) Edges Higher: Testing Key Resistance Near $6.92 - Long Setup Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOT0EyZmpwZ0dQOGpKQ3cwSnl3QUV0SFBDVmllZi0zZ01iYzVCNG9LeGlKeDhDZEZyTHJqalR6RVZSTUJKRTdZRTFvTE5ZU0tsbGpxMEVheERhOFNPVTUyWlRwMWVGU2hudFhYM3dWd3R2NzQtc0hSLVU5a1pMdHoydDRPVG1oUXNLSU96Sk5ZZFlJV19hVWVvOFVsS3FkWHp6Zl8zbHlwU19QNEFXNXlwV04wMEMyUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-29T21:36:17+00:00", "published_display": "29 Jun 2026 21:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp. (PROF) Edges Higher: Testing Key Resistance Near $6.92 - Calendar Spread Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNaWN1SVlHcjY4eF9qNjQ4V0twbHRqLVktdk1KZ3lHdGxTWHBOQUVJV2J0SzJTcU9fU0o4LW1Fcno4emw5YzRYdnZ4WnpubWVoejNRUHRDSGxRckRMTnB4T3dtZVdVUEplY1JRbWFDY1lzaHZFQTQ2anJSVWRZWGgyWFdJVEFReTc3bEJFbkd0cVBDLWM5VjhSV2lyOUJHQ0Q3Mm5jdXpEd2V0V01tWE13V1BKWTFWTmtXdkk0Tw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Behavioral Patterns of PROF and Institutional Flows", "summary": "This article analyzes Profound Medical Corp. (NASDAQ: PROF) using AI models to identify behavioral patterns and institutional flows. It highlights a weak near-term sentiment but strong long-term outlook, with a mid-channel oscillation pattern in play. The analysis provides specif", "url": "https://news.stocktradersdaily.com/news_release/141/Behavioral_Patterns_of_PROF_and_Institutional_Flows_062826105002_1782658202.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-28T10:50:00", "published_display": "28 Jun 2026 10:50", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROF Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Profound Medical Corp. (PROF) for 2027, based on analyst opinions. It includes details on the company's financial performance, such as recent earnings and revenue, and addresses frequently asked questions about its stock, incl", "url": "https://www.tradingview.com/symbols/BOATS-PROF/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T03:10:53", "published_display": "27 Jun 2026 03:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp. (PROF) Dropped Despite High Potential", "summary": "Profound Medical Corp. (PROF) was highlighted by Grow Funds in its Q1 2026 investor letter as a commercial-stage medical device company focused on AI-powered, MRI-guided therapeutic systems for treating prostate cancer. Despite its innovative TULSA-PRO\u00ae technology and pipeline of", "url": "https://uk.finance.yahoo.com/news/profound-medical-corp-prof-dropped-142828470.html", "source_name": "Market source", "published_at": "2026-06-22T14:28:00", "published_display": "22 Jun 2026 14:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp (PROF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Profound Medical Corp (PROF), detailing its regional revenue contribution. As of the latest disclosure, the company's revenue primarily comes from the USA (76.07%), followed by Canada (19.13%) and Germany (4.80%). Data regarding reven", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prof/revenue", "source_name": "TradingKey", "published_at": "2026-06-22T00:40:23", "published_display": "22 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp (PROF) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Profound Medical Corp (PROF) has an earnings forecast score of 8.80, ranking 10th in the Healthcare Equipment & Supplies industry. Analysts have an average price target of $11.12 with a \"Buy\" consensus based on 5 analysts. The company's expected revenue for the next quarter is $5", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prof/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T21:18:08", "published_display": "17 Jun 2026 21:18", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(PROF) Movement Within Algorithmic Entry Frameworks", "summary": "This article provides an algorithmic analysis of Profound Medical Corp. (NASDAQ: PROF), identifying a neutral near and mid-term outlook with a long-term positive bias. It details exceptional short setup risk-reward, outlines specific institutional trading strategies including pos", "url": "https://news.stocktradersdaily.com/news_release/149/PROF_Movement_Within_Algorithmic_Entry_Frameworks_061726093803_1781703483.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-17T09:38:00", "published_display": "17 Jun 2026 09:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp (PROF) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Profound Medical Corp (PROF), detailing its current price momentum, support and resistance levels, and indicator and moving average readings. It notes that PROF's price momentum score is 6.93, trading between a resistance of 7.16 and ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prof/technical", "source_name": "TradingKey", "published_at": "2026-06-16T22:40:40", "published_display": "16 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROF - Profound Medical Corp Stock Price and Quote", "summary": "This page provides a comprehensive overview of Profound Medical Corp (PROF) stock, including its latest stock price, financial data, company profile, and recent news. It details key financial metrics, stock performance, analyst ratings, and a chronological list of company announc", "url": "https://finviz.com/stock?t=PROF", "source_name": "Finviz", "published_at": "2026-06-10T07:40:16", "published_display": "10 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (Nasdaq:PROF) - Stock Analysis", "summary": "This Simply Wall St analysis of Profound Medical (Nasdaq: PROF) highlights its status as a commercial-stage medical device company focused on AI-powered, MRI-guided therapeutic systems. The company shows strong future growth potential with earnings forecast to grow by 54.03% annu", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-prof/profound-medical", "source_name": "Simply Wall Street", "published_at": "2026-06-04T18:40:14", "published_display": "04 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (TSX:PRN) Stock Forecast & Analyst Predictions", "summary": "Profound Medical (TSX:PRN) is projected to achieve profitability within the next three years, with analysts forecasting significant growth in earnings and revenue. The company's TULSA-PRO system has shown promising results in clinical trials for prostate cancer and benign prostat", "url": "https://simplywall.st/stocks/ca/healthcare/tsx-prn/profound-medical-shares/future", "source_name": "Simply Wall Street", "published_at": "2026-05-27T02:39:08", "published_display": "27 May 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (TSX:PRN) - Stock Analysis", "summary": "Profound Medical Corp. (TSX:PRN) is a commercial-stage medical device company specializing in AI-powered, MRI-guided therapeutic systems for treating diseased tissue. The company's flagship TULSA-PRO system, used for prostate cancer and BPH, recently demonstrated superior functio", "url": "https://simplywall.st/stocks/ca/healthcare/tsx-prn/profound-medical-shares", "source_name": "Simply Wall Street", "published_at": "2026-05-27T02:09:20", "published_display": "27 May 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] Profound Medical Corp. SEC Filing", "summary": "Profound Medical Corp. (NASDAQ: PROF) has announced an SEC Filing for Form EFFECT, indicating the effectiveness of its S-3 Shelf Registration Statement as of May 19, 2026, at 4:30 P.M. The filing shows a neutral impact and sentiment according to Rhea-AI. Profound Medical Corp. ha", "url": "https://www.stocktitan.net/sec-filings/PROF/effect-profound-medical-corp-sec-filing-7f937f7158b6.html", "source_name": "Stock Titan", "published_at": "2026-05-20T10:35:22", "published_display": "20 May 2026 10:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPc0tLLTA5U3FOMVB5LUJXQ1FYTFk0dm8xMTBkQUswcnpEamZjWFJ1V1FQODh3SEIwQld3MmwwdG1JSW9ESDJRU0d6aWJzSkdueGpXME1iLWpTVW4zMjhtWEExM0RWVF9qWEtCRUx5cTBWMk13U3JNVTgtZllTeVVfWnNXeEJiRlBFVVIzczBBOFZVN2Zudmc4?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Shareholders Back Board, Question Incentive Plan", "summary": "Profound Medical Corp. shareholders re-elected their existing board of directors with strong majorities and reappointed PricewaterhouseCoopers LLP as auditors. However, a significant 36% opposition was noted for the approval of unallocated restricted and deferred share units unde", "url": "https://www.theglobeandmail.com/investing/markets/stocks/PROF/pressreleases/1978233/profound-medical-shareholders-back-board-question-incentive-plan/", "source_name": "The Globe and Mail", "published_at": "2026-05-17T10:11:09", "published_display": "17 May 2026 10:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Annual General and Special Meeting of Shareholders Voting Results", "summary": "Profound Medical Corp. announced the voting results from its Annual General and Special Meeting of Shareholders, where all eight director nominees were elected and the appointment of PricewaterhouseCoopers LLP as auditor was approved. Shareholders also approved unallocated restri", "url": "https://www.tradingview.com/news/tmx_newsfile:b4997e5c5094b:0-profound-medical-annual-general-and-special-meeting-of-shareholders-voting-results/", "source_name": "TradingView", "published_at": "2026-05-15T23:40:41", "published_display": "15 May 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (NASDAQ: PROF) investors back board, auditor and long\u2011term incentive units", "summary": "Profound Medical Corp. (NASDAQ: PROF) shareholders approved the election of eight directors, the reappointment of PricewaterhouseCoopers LLP as auditors with 99.497% support, and confirmed all unallocated restricted and deferred share units under its long-term incentive plan. The", "url": "https://www.stocktitan.net/sec-filings/PROF/8-k-profound-medical-corp-reports-material-event-e31cae8b7432.html", "source_name": "Stock Titan", "published_at": "2026-05-15T20:09:33", "published_display": "15 May 2026 20:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix to Collaborate With EDAP, Profound Medical to Explore PSMA-PET Imaging in Prostate Cancer Therapies", "summary": "Telix Pharmaceuticals announced collaborations with EDAP TMS and Profound Medical to investigate the role of PSMA-PET imaging in guiding and monitoring prostate cancer therapies. The goal is to enhance treatment precision and patient outcomes by integrating advanced imaging with ", "url": "https://www.moomoo.com/news/post/70091957/telix-to-collaborate-with-edap-profound-medical-to-explore-psma", "source_name": "Moomoo", "published_at": "2026-05-15T12:09:33", "published_display": "15 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Profound Medical Corp. (PROF) Affects Rotational Strategy Timing", "summary": "Profound Medical Corp. (PROF) shows neutral near-term sentiment but strong mid and long-term strength, with support being tested. The company has an exceptional 74.0:1 risk-reward setup, targeting a 21.0% gain against 0.3% risk. AI models have generated distinct trading strategie", "url": "https://news.stocktradersdaily.com/news_release/10/How_Profound_Medical_Corp._PROF_Affects_Rotational_Strategy_Timing_051526055201_1778838721.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-15T05:52:00", "published_display": "15 May 2026 05:52", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Highlights TULSA Advances at AUA 2026", "summary": "Profound Medical's TULSA Procedure will be a focal point at AUA2026 with four presentations detailing its safety, efficacy, and functional outcomes in treating localized prostate cancer. The company plans to integrate PSMA PET imaging with its TULSA-PRO platform to improve treatm", "url": "https://www.tipranks.com/news/company-announcements/profound-medical-highlights-tulsa-advances-at-aua-2026", "source_name": "TipRanks", "published_at": "2026-05-14T23:39:51", "published_display": "14 May 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (NASDAQ: PROF) to highlight TULSA and PSMA PET integration at AUA2026", "summary": "Profound Medical Corp. announced plans to showcase its MRI-guided TULSA Procedure\u2122 at the American Urological Association's 2026 Annual Meeting, featuring four oral presentations and demonstrations of TULSA-PRO\u00ae. The company also unveiled an initiative to integrate PSMA PET molec", "url": "https://www.stocktitan.net/sec-filings/PROF/8-k-profound-medical-corp-reports-material-event-178de084c207.html", "source_name": "Stock Titan", "published_at": "2026-05-14T20:39:51", "published_display": "14 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound to Showcase TULSA-PRO\u00ae, the TULSA Procedure\u2122 and the Future of iMRI at AUA2026", "summary": "Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) announced that its TULSA Procedure\u2122 will be highlighted in four oral presentations at the upcoming American Urological Association\u2019s (AUA) Annual Meeting. The company will also showcase its TULSA-PRO\u00ae and an actual Siemens MAGNETOM Fr", "url": "https://www.manilatimes.net/2026/05/14/tmt-newswire/globenewswire/profound-to-showcase-tulsa-pro-the-tulsa-procedure-and-the-future-of-imri-at-aua2026/2343799/amp", "source_name": "The Manila Times", "published_at": "2026-05-14T11:39:51", "published_display": "14 May 2026 11:39", "sentiment": "positive", "sentiment_pct": 86, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Q1 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQSk0yajctWjdMQjdqQVp2cHg1M1ViQTFwRjBXRFJtZzRQUEUzX194aVotOHlaYW1ZWGJvLXBvQ291QW1CUi03UlptTXdIdlNRWFFEd1J2RllBRklLZFItVHBIbndqZi1zaWwtYzVFR3d0ZXNtRkxoWlMweEttT2VuRFhhMlBvWG84bGRLRGhVWnJobXNTNmhFTU5CbG01RDdrdTVPejVWTGs?oc=5", "source_name": "TradingView", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Reports Strong First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxORWIwMVRhQW9NeFQ3NkFZOENETkZuSVFHT2VOT1luQ211LXRONl9kWnhqaWJrSjhJVHg1Q08wNlNSM3BSaF9OeklLZUZuMFB6eDlSZUxyZ25MeGZCTEdodHYwRy1MdnBKQjkwTzZPdlZkUDVWVjVzWmJ2bV9jVE9FTEQycEJiU3MzZmFtS3IyalAxVnRON2luOGI4dw?oc=5", "source_name": "Investing News Network", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNc21XRzFuY25EemM0Vk9uYVJYYzlYOW9UUlhvTGNTaVJ2ZWpTUGZVbFFaMFg0MUZVRHllV1NFN0NlY3RGMXVmM05MbnNMWk1RdzhVbjJrVmxCVEwwN1pOVk5WSUJpQndjUU5SYTRlR2VOMzdBU1NyYkZRVVR2X0pqN0M4YlJ0ak5qRDBjWFcyY0hJWVo1WHh2OC1kaGczZ0tZRGx3?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQdDV1YldYQ2lWekQwaEtpckNTMWtDdDM4czRzenJZcU44OG9Jb1FyZTcxanZDSnFNWDZXd3Nzc1RwSC1lNXdIVlNPQjVBRzY5YzM5eVlqT2xrbWpKNm5kXzd5bVg4dWw0VU9JU1NSZlJxSkM3Um03ajNaaTVqTEFjZDNSMVR5N3IteENiNm1pa1VHd190d0stUnk4Q2xzcV94WkVLNF9n?oc=5", "source_name": "Investing News Network", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNV0R5RWVPWnVLcm5VX2J0UWtUaERGWlF2eUtNTmFtTjBoRGMtUlN0aUEwM3pISGlKMnhRdXFRMVVyMUtOY2dNdGVzZm02Q3NvT3BrdmoyRjM1cUZhWmN3bk12Nlpib2w2YlRNcDlvQzMzaVBsd1NvUWQzS2xHeEd5WGhYRjg5eV9aeExOUVhNaWZPM3JKcGg2MGs3dzdFTUozX1B6WGgyNUFzWTNFbDRZWTdFa1BMSGs?oc=5", "source_name": "Investing News Network", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp._December 31, 2024", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPNkx2bXZ3aWFnaTBZNHVCUE9WWkxQSkpxNzVCWVBGS0t0SjQ4MllwbkFTbmhfRHAzN1hzWmdhSjNoZTM5bUsxS1djNFFNbGFfSWxNMlBPZEszeDNRTlJlSmtyN05mSmU2eTNoVHlFUkpYeGgwNEhXY2JINDdpNWhmT1o0b001YnRRb1VOVHpicHVBdw?oc=5", "source_name": "SEC.gov", "published_at": "2025-03-08T06:03:05+00:00", "published_display": "08 Mar 2025 06:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical is a Strong Buy, says Raymond James", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQcXRkQUZXUEVqdlhIWXl5UUZ0QXRoLWdhWS15Mnp1eEY4NmlLY1ViQ1FHbXRTRDV5Ty1HeEw4aGJqVnlVUEJDWWhRYjRRSmRxb0JwWDZXU0dlWkVscDR5WXRKcUstaVZYWnFlTVV3d0xNbENqdThjQWNqVFBVZXYzdGREMEpPMXByYUJ4NjQwZC1SYnoxTlpB0gGcAUFVX3lxTE9ZeDQza2hGdGF4SGlsOVZNeFhreXlZandnSlYwTEdJSnJTM3hVS1Y4cC1EV2ViUERyVEtxdXFtV2tVc3FvV3I3ZkYtOURfcm9aUHNuX24zb0F4RE9xQ2duX1RHTTloQV9PSDdEMENiSkNqaHVFMVh5cmVNNFZYZzVKNml2UmtMZTRjci1ka0lnLXV6S2lFV3VTQ0RKLQ?oc=5", "source_name": "Cantech Letter", "published_at": "2023-04-11T07:00:00+00:00", "published_display": "11 Apr 2023 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (PROF) Stock Price, News & Analysis $PROF", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9iM2tXeEZJckJlZ2lpSjNMSC13ZVFNeG9FV0Jqa2tTVTU2cGxzZEhGZHFHNmk0eVRoc0o2LUlqNk1yX0EzRzNKZU5nU3d1aXdEME9aVXBxUzlKZw?oc=5", "source_name": "MarketBeat", "published_at": "2020-10-22T03:39:51+00:00", "published_display": "22 Oct 2020 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TULSA-PRO is looking like a winner for Profound Medical: Raymond James", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOV19XeXprX0xzb1NhTkJueGUzZGJOenRrWTNhaUxHbkxkV2lPbmtQX05YOElFVzYxN2VTSGFEYjhRRGlET1hQa1RYQWoyT25abGVReFppR3Nkb1FpTTFBNzY1UThIcnNDN0VXZjdkRU5WTHh6cEVTdG9jOWdsSWJLQ0lmNWY3c1NNNmdqSlJ6VFBKUm5UanNTc2dkM1FCNmNlZVZiaVl2YW9velVx0gGyAUFVX3lxTE8xQ1VXcnM5QmJ0TVd3WmpHbkVydjgwMXBuZWQwLVQyNU02U05vbldRaUtwNGNGY2NxX0FpdVNhRHBwdXBfTGFZb1BqbUdpS1VhVDlDZnN5V2twWFpwUGtxYmZNZXZMZTZLeVI0SFdaeTF0WUNQN2tGYWU0MG44WTBnbTRLYlRsWkdWUHFnTl9RRGdaSUNCN3JxbDdUZkpGaTRWT2E0OEo0YV9MdnB5YmF6enc?oc=5", "source_name": "Cantech Letter", "published_at": "2019-11-26T08:00:00+00:00", "published_display": "26 Nov 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Company Profile: Profound Medical", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5pMDlzMkxucUpncWQ5MkxwdXFRT0FuTVpvQlpEdmdRMXBwaVY1QXp5RjdpUFFFX09Gb280QjdXUTRsZ2FPNl9mbklxd2Z5MXFycWNzYTVKblBKaFNJY0QxOFFzc2RzcnRvekNzV2F6a0drd3RtMk80eA?oc=5", "source_name": "Focused Ultrasound Foundation", "published_at": "2018-03-21T07:00:00+00:00", "published_display": "21 Mar 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Profound Medical Corp.", "summary": "Profound Medical Corp. announced that its TULSA Procedure\u2122 will be featured in multiple presentations by leading physicians at the upcoming Society of Robotic Surgery Annual Meeting in Fort Lauderdale, FL, from July 23-26. Shares of Profound Medical Corp. (T.PRN) were trading up ", "url": "https://www.baystreet.ca/stocksinplayarticles/47557/Stocks-in-Play-Profound-Medical-Corp", "source_name": "Baystreet.ca", "published_at": "2026-07-15T14:40:35", "published_display": "15 Jul 2026 14:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical to Highlight TULSA Procedure at SRS2026, Multiple Presentations and Investor Session", "summary": "Profound Medical will showcase its MRI-guided, AI-powered TULSA Procedure at the SRS2026 Annual Meeting through multiple expert presentations and an investor session. The event will feature presentations on real-world and trial outcomes, including primary safety results from the ", "url": "https://www.tradingview.com/news/tradingview:5a0ac6d2adcbb:0-profound-medical-to-highlight-tulsa-procedure-at-srs2026-multiple-presentations-and-investor-session/", "source_name": "TradingView", "published_at": "2026-07-15T11:40:35", "published_display": "15 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical's TULSA joins 8-company SRS surgery spotlight", "summary": "Profound Medical's (NASDAQ:PROF) TULSA Procedure will be prominently featured at the Society of Robotic Surgery (SRS) Annual Meeting in Fort Lauderdale, FL, from July 23-26, 2026. The MRI-guided, AI-powered, robotically driven technology will be highlighted in multiple physician-", "url": "https://www.stocktitan.net/news/PROF/profound-medical-autonomous-robotics-and-incisionless-surgery-to-rnj381katrgl.html", "source_name": "Stock Titan", "published_at": "2026-07-15T11:40:35", "published_display": "15 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (NASDAQ: PROF) plans strong TULSA presence at SRS2026", "summary": "Profound Medical Corp. announced a significant presence for its TULSA Procedure at the Society of Robotic Surgery Annual Meeting (SRS2026) from July 23-26, 2026, in Fort Lauderdale, FL. The MRI-guided, AI-powered treatment for prostate cancer will be highlighted in multiple physi", "url": "https://www.stocktitan.net/sec-filings/PROF/8-k-profound-medical-corp-reports-material-event-ba00b4e447b5.html", "source_name": "Stock Titan", "published_at": "2026-07-15T11:40:34", "published_display": "15 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026", "summary": "Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) announced its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure\u2122 will be prominently featured at the Society of Robotic Surgery (SRS) Annual Meeting from July 23-26, 2026. Leading physicians will present on", "url": "https://sg.finance.yahoo.com/news/profound-medical-autonomous-robotics-incisionless-114500643.html", "source_name": "Market source", "published_at": "2026-07-15T11:40:34", "published_display": "15 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Discipline and Rules-Based Execution in PROF Response", "summary": "This article provides an in-depth analysis of Profound Medical Corp. (NASDAQ: PROF), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines distinct institutional trading strategies, including position trading, momentum breakout, and risk hed", "url": "https://news.stocktradersdaily.com/news_release/134/Discipline_and_Rules-Based_Execution_in_PROF_Response_070926115802_1783612682.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-09T12:18:24", "published_display": "09 Jul 2026 12:18", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOMlFhV3NXRWptNTFVc0dXcVNQYkswdG80eF9UU1I5VHdxZ3Ntc1VsS3AxSWJFc3hzMVdYS29LZ0V3djhTMGdHQWZMcDFuQnhyX1VtbUJRM1RoNm9rRHdna0pJOXBDMVRRTUpDOEF0OXhhX3V2Q05QQ25iV3N0ekFKT3ZkN3REOWVtZi1QOVZfZTJGYzBGZnFVVHdB?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp. (PROF) Edges Higher as Support Holds Near $6.50 - Put Dominated", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNNHpBaE9NZkxOdGFsUU1FLThqQURERjVLU19RRk9zOFRDdW1Xblg3bzBIdGVhQWFoTWdoMm02VjA4bGNILWpRUDhyY2xrZ00xRms5SmhFT3R0RzBnWkVBZExqSEYzdG5tc3dibXZxQ0VSa0FiMW1qeThLSFJrSzJSWThRWGVtOU1pZnNRVEpkZmc1aE11V2RZTG8tZlJ2SWtHOWpWSmlScVFIX1E?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-05T22:48:26+00:00", "published_display": "05 Jul 2026 22:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Profound Medical Corp \u2013 TSX:PRN", "summary": "This page provides financial information for Profound Medical Corp (TSX:PRN), specifically focusing on its forward price-to-earnings ratio. It indicates that the market is closed with no recent trades for the company. The page also lists various data providers and copyright infor", "url": "https://www.tradingview.com/symbols/TSX-PRN/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T01:10:41", "published_display": "05 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp. (PROF) Edges Higher: Testing Key Resistance Near $6.92 - Long Setup Ideas", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOT0EyZmpwZ0dQOGpKQ3cwSnl3QUV0SFBDVmllZi0zZ01iYzVCNG9LeGlKeDhDZEZyTHJqalR6RVZSTUJKRTdZRTFvTE5ZU0tsbGpxMEVheERhOFNPVTUyWlRwMWVGU2hudFhYM3dWd3R2NzQtc0hSLVU5a1pMdHoydDRPVG1oUXNLSU96Sk5ZZFlJV19hVWVvOFVsS3FkWHp6Zl8zbHlwU19QNEFXNXlwV04wMEMyUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-29T21:36:17+00:00", "published_display": "29 Jun 2026 21:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp. (PROF) Edges Higher: Testing Key Resistance Near $6.92 - Calendar Spread Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNaWN1SVlHcjY4eF9qNjQ4V0twbHRqLVktdk1KZ3lHdGxTWHBOQUVJV2J0SzJTcU9fU0o4LW1Fcno4emw5YzRYdnZ4WnpubWVoejNRUHRDSGxRckRMTnB4T3dtZVdVUEplY1JRbWFDY1lzaHZFQTQ2anJSVWRZWGgyWFdJVEFReTc3bEJFbkd0cVBDLWM5VjhSV2lyOUJHQ0Q3Mm5jdXpEd2V0V01tWE13V1BKWTFWTmtXdkk0Tw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Behavioral Patterns of PROF and Institutional Flows", "summary": "This article analyzes Profound Medical Corp. (NASDAQ: PROF) using AI models to identify behavioral patterns and institutional flows. It highlights a weak near-term sentiment but strong long-term outlook, with a mid-channel oscillation pattern in play. The analysis provides specif", "url": "https://news.stocktradersdaily.com/news_release/141/Behavioral_Patterns_of_PROF_and_Institutional_Flows_062826105002_1782658202.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-28T10:50:00", "published_display": "28 Jun 2026 10:50", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROF Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Profound Medical Corp. (PROF) for 2027, based on analyst opinions. It includes details on the company's financial performance, such as recent earnings and revenue, and addresses frequently asked questions about its stock, incl", "url": "https://www.tradingview.com/symbols/BOATS-PROF/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T03:10:53", "published_display": "27 Jun 2026 03:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp. (PROF) Dropped Despite High Potential", "summary": "Profound Medical Corp. (PROF) was highlighted by Grow Funds in its Q1 2026 investor letter as a commercial-stage medical device company focused on AI-powered, MRI-guided therapeutic systems for treating prostate cancer. Despite its innovative TULSA-PRO\u00ae technology and pipeline of", "url": "https://uk.finance.yahoo.com/news/profound-medical-corp-prof-dropped-142828470.html", "source_name": "Market source", "published_at": "2026-06-22T14:28:00", "published_display": "22 Jun 2026 14:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp (PROF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Profound Medical Corp (PROF), detailing its regional revenue contribution. As of the latest disclosure, the company's revenue primarily comes from the USA (76.07%), followed by Canada (19.13%) and Germany (4.80%). Data regarding reven", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prof/revenue", "source_name": "TradingKey", "published_at": "2026-06-22T00:40:23", "published_display": "22 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp (PROF) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Profound Medical Corp (PROF) has an earnings forecast score of 8.80, ranking 10th in the Healthcare Equipment & Supplies industry. Analysts have an average price target of $11.12 with a \"Buy\" consensus based on 5 analysts. The company's expected revenue for the next quarter is $5", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prof/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T21:18:08", "published_display": "17 Jun 2026 21:18", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(PROF) Movement Within Algorithmic Entry Frameworks", "summary": "This article provides an algorithmic analysis of Profound Medical Corp. (NASDAQ: PROF), identifying a neutral near and mid-term outlook with a long-term positive bias. It details exceptional short setup risk-reward, outlines specific institutional trading strategies including pos", "url": "https://news.stocktradersdaily.com/news_release/149/PROF_Movement_Within_Algorithmic_Entry_Frameworks_061726093803_1781703483.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-17T09:38:00", "published_display": "17 Jun 2026 09:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp (PROF) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Profound Medical Corp (PROF), detailing its current price momentum, support and resistance levels, and indicator and moving average readings. It notes that PROF's price momentum score is 6.93, trading between a resistance of 7.16 and ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-prof/technical", "source_name": "TradingKey", "published_at": "2026-06-16T22:40:40", "published_display": "16 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PROF - Profound Medical Corp Stock Price and Quote", "summary": "This page provides a comprehensive overview of Profound Medical Corp (PROF) stock, including its latest stock price, financial data, company profile, and recent news. It details key financial metrics, stock performance, analyst ratings, and a chronological list of company announc", "url": "https://finviz.com/stock?t=PROF", "source_name": "Finviz", "published_at": "2026-06-10T07:40:16", "published_display": "10 Jun 2026 07:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (Nasdaq:PROF) - Stock Analysis", "summary": "This Simply Wall St analysis of Profound Medical (Nasdaq: PROF) highlights its status as a commercial-stage medical device company focused on AI-powered, MRI-guided therapeutic systems. The company shows strong future growth potential with earnings forecast to grow by 54.03% annu", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-prof/profound-medical", "source_name": "Simply Wall Street", "published_at": "2026-06-04T18:40:14", "published_display": "04 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (TSX:PRN) Stock Forecast & Analyst Predictions", "summary": "Profound Medical (TSX:PRN) is projected to achieve profitability within the next three years, with analysts forecasting significant growth in earnings and revenue. The company's TULSA-PRO system has shown promising results in clinical trials for prostate cancer and benign prostat", "url": "https://simplywall.st/stocks/ca/healthcare/tsx-prn/profound-medical-shares/future", "source_name": "Simply Wall Street", "published_at": "2026-05-27T02:39:08", "published_display": "27 May 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (TSX:PRN) - Stock Analysis", "summary": "Profound Medical Corp. (TSX:PRN) is a commercial-stage medical device company specializing in AI-powered, MRI-guided therapeutic systems for treating diseased tissue. The company's flagship TULSA-PRO system, used for prostate cancer and BPH, recently demonstrated superior functio", "url": "https://simplywall.st/stocks/ca/healthcare/tsx-prn/profound-medical-shares", "source_name": "Simply Wall Street", "published_at": "2026-05-27T02:09:20", "published_display": "27 May 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] Profound Medical Corp. SEC Filing", "summary": "Profound Medical Corp. (NASDAQ: PROF) has announced an SEC Filing for Form EFFECT, indicating the effectiveness of its S-3 Shelf Registration Statement as of May 19, 2026, at 4:30 P.M. The filing shows a neutral impact and sentiment according to Rhea-AI. Profound Medical Corp. ha", "url": "https://www.stocktitan.net/sec-filings/PROF/effect-profound-medical-corp-sec-filing-7f937f7158b6.html", "source_name": "Stock Titan", "published_at": "2026-05-20T10:35:22", "published_display": "20 May 2026 10:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPc0tLLTA5U3FOMVB5LUJXQ1FYTFk0dm8xMTBkQUswcnpEamZjWFJ1V1FQODh3SEIwQld3MmwwdG1JSW9ESDJRU0d6aWJzSkdueGpXME1iLWpTVW4zMjhtWEExM0RWVF9qWEtCRUx5cTBWMk13U3JNVTgtZllTeVVfWnNXeEJiRlBFVVIzczBBOFZVN2Zudmc4?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Shareholders Back Board, Question Incentive Plan", "summary": "Profound Medical Corp. shareholders re-elected their existing board of directors with strong majorities and reappointed PricewaterhouseCoopers LLP as auditors. However, a significant 36% opposition was noted for the approval of unallocated restricted and deferred share units unde", "url": "https://www.theglobeandmail.com/investing/markets/stocks/PROF/pressreleases/1978233/profound-medical-shareholders-back-board-question-incentive-plan/", "source_name": "The Globe and Mail", "published_at": "2026-05-17T10:11:09", "published_display": "17 May 2026 10:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Annual General and Special Meeting of Shareholders Voting Results", "summary": "Profound Medical Corp. announced the voting results from its Annual General and Special Meeting of Shareholders, where all eight director nominees were elected and the appointment of PricewaterhouseCoopers LLP as auditor was approved. Shareholders also approved unallocated restri", "url": "https://www.tradingview.com/news/tmx_newsfile:b4997e5c5094b:0-profound-medical-annual-general-and-special-meeting-of-shareholders-voting-results/", "source_name": "TradingView", "published_at": "2026-05-15T23:40:41", "published_display": "15 May 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (NASDAQ: PROF) investors back board, auditor and long\u2011term incentive units", "summary": "Profound Medical Corp. (NASDAQ: PROF) shareholders approved the election of eight directors, the reappointment of PricewaterhouseCoopers LLP as auditors with 99.497% support, and confirmed all unallocated restricted and deferred share units under its long-term incentive plan. The", "url": "https://www.stocktitan.net/sec-filings/PROF/8-k-profound-medical-corp-reports-material-event-e31cae8b7432.html", "source_name": "Stock Titan", "published_at": "2026-05-15T20:09:33", "published_display": "15 May 2026 20:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Telix to Collaborate With EDAP, Profound Medical to Explore PSMA-PET Imaging in Prostate Cancer Therapies", "summary": "Telix Pharmaceuticals announced collaborations with EDAP TMS and Profound Medical to investigate the role of PSMA-PET imaging in guiding and monitoring prostate cancer therapies. The goal is to enhance treatment precision and patient outcomes by integrating advanced imaging with ", "url": "https://www.moomoo.com/news/post/70091957/telix-to-collaborate-with-edap-profound-medical-to-explore-psma", "source_name": "Moomoo", "published_at": "2026-05-15T12:09:33", "published_display": "15 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Profound Medical Corp. (PROF) Affects Rotational Strategy Timing", "summary": "Profound Medical Corp. (PROF) shows neutral near-term sentiment but strong mid and long-term strength, with support being tested. The company has an exceptional 74.0:1 risk-reward setup, targeting a 21.0% gain against 0.3% risk. AI models have generated distinct trading strategie", "url": "https://news.stocktradersdaily.com/news_release/10/How_Profound_Medical_Corp._PROF_Affects_Rotational_Strategy_Timing_051526055201_1778838721.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-15T05:52:00", "published_display": "15 May 2026 05:52", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Highlights TULSA Advances at AUA 2026", "summary": "Profound Medical's TULSA Procedure will be a focal point at AUA2026 with four presentations detailing its safety, efficacy, and functional outcomes in treating localized prostate cancer. The company plans to integrate PSMA PET imaging with its TULSA-PRO platform to improve treatm", "url": "https://www.tipranks.com/news/company-announcements/profound-medical-highlights-tulsa-advances-at-aua-2026", "source_name": "TipRanks", "published_at": "2026-05-14T23:39:51", "published_display": "14 May 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (NASDAQ: PROF) to highlight TULSA and PSMA PET integration at AUA2026", "summary": "Profound Medical Corp. announced plans to showcase its MRI-guided TULSA Procedure\u2122 at the American Urological Association's 2026 Annual Meeting, featuring four oral presentations and demonstrations of TULSA-PRO\u00ae. The company also unveiled an initiative to integrate PSMA PET molec", "url": "https://www.stocktitan.net/sec-filings/PROF/8-k-profound-medical-corp-reports-material-event-178de084c207.html", "source_name": "Stock Titan", "published_at": "2026-05-14T20:39:51", "published_display": "14 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound to Showcase TULSA-PRO\u00ae, the TULSA Procedure\u2122 and the Future of iMRI at AUA2026", "summary": "Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) announced that its TULSA Procedure\u2122 will be highlighted in four oral presentations at the upcoming American Urological Association\u2019s (AUA) Annual Meeting. The company will also showcase its TULSA-PRO\u00ae and an actual Siemens MAGNETOM Fr", "url": "https://www.manilatimes.net/2026/05/14/tmt-newswire/globenewswire/profound-to-showcase-tulsa-pro-the-tulsa-procedure-and-the-future-of-imri-at-aua2026/2343799/amp", "source_name": "The Manila Times", "published_at": "2026-05-14T11:39:51", "published_display": "14 May 2026 11:39", "sentiment": "positive", "sentiment_pct": 86, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Q1 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQSk0yajctWjdMQjdqQVp2cHg1M1ViQTFwRjBXRFJtZzRQUEUzX194aVotOHlaYW1ZWGJvLXBvQ291QW1CUi03UlptTXdIdlNRWFFEd1J2RllBRklLZFItVHBIbndqZi1zaWwtYzVFR3d0ZXNtRkxoWlMweEttT2VuRFhhMlBvWG84bGRLRGhVWnJobXNTNmhFTU5CbG01RDdrdTVPejVWTGs?oc=5", "source_name": "TradingView", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Reports Strong First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxORWIwMVRhQW9NeFQ3NkFZOENETkZuSVFHT2VOT1luQ211LXRONl9kWnhqaWJrSjhJVHg1Q08wNlNSM3BSaF9OeklLZUZuMFB6eDlSZUxyZ25MeGZCTEdodHYwRy1MdnBKQjkwTzZPdlZkUDVWVjVzWmJ2bV9jVE9FTEQycEJiU3MzZmFtS3IyalAxVnRON2luOGI4dw?oc=5", "source_name": "Investing News Network", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNc21XRzFuY25EemM0Vk9uYVJYYzlYOW9UUlhvTGNTaVJ2ZWpTUGZVbFFaMFg0MUZVRHllV1NFN0NlY3RGMXVmM05MbnNMWk1RdzhVbjJrVmxCVEwwN1pOVk5WSUJpQndjUU5SYTRlR2VOMzdBU1NyYkZRVVR2X0pqN0M4YlJ0ak5qRDBjWFcyY0hJWVo1WHh2OC1kaGczZ0tZRGx3?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQdDV1YldYQ2lWekQwaEtpckNTMWtDdDM4czRzenJZcU44OG9Jb1FyZTcxanZDSnFNWDZXd3Nzc1RwSC1lNXdIVlNPQjVBRzY5YzM5eVlqT2xrbWpKNm5kXzd5bVg4dWw0VU9JU1NSZlJxSkM3Um03ajNaaTVqTEFjZDNSMVR5N3IteENiNm1pa1VHd190d0stUnk4Q2xzcV94WkVLNF9n?oc=5", "source_name": "Investing News Network", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNV0R5RWVPWnVLcm5VX2J0UWtUaERGWlF2eUtNTmFtTjBoRGMtUlN0aUEwM3pISGlKMnhRdXFRMVVyMUtOY2dNdGVzZm02Q3NvT3BrdmoyRjM1cUZhWmN3bk12Nlpib2w2YlRNcDlvQzMzaVBsd1NvUWQzS2xHeEd5WGhYRjg5eV9aeExOUVhNaWZPM3JKcGg2MGs3dzdFTUozX1B6WGgyNUFzWTNFbDRZWTdFa1BMSGs?oc=5", "source_name": "Investing News Network", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical Corp._December 31, 2024", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPNkx2bXZ3aWFnaTBZNHVCUE9WWkxQSkpxNzVCWVBGS0t0SjQ4MllwbkFTbmhfRHAzN1hzWmdhSjNoZTM5bUsxS1djNFFNbGFfSWxNMlBPZEszeDNRTlJlSmtyN05mSmU2eTNoVHlFUkpYeGgwNEhXY2JINDdpNWhmT1o0b001YnRRb1VOVHpicHVBdw?oc=5", "source_name": "SEC.gov", "published_at": "2025-03-08T06:03:05+00:00", "published_display": "08 Mar 2025 06:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical is a Strong Buy, says Raymond James", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQcXRkQUZXUEVqdlhIWXl5UUZ0QXRoLWdhWS15Mnp1eEY4NmlLY1ViQ1FHbXRTRDV5Ty1HeEw4aGJqVnlVUEJDWWhRYjRRSmRxb0JwWDZXU0dlWkVscDR5WXRKcUstaVZYWnFlTVV3d0xNbENqdThjQWNqVFBVZXYzdGREMEpPMXByYUJ4NjQwZC1SYnoxTlpB0gGcAUFVX3lxTE9ZeDQza2hGdGF4SGlsOVZNeFhreXlZandnSlYwTEdJSnJTM3hVS1Y4cC1EV2ViUERyVEtxdXFtV2tVc3FvV3I3ZkYtOURfcm9aUHNuX24zb0F4RE9xQ2duX1RHTTloQV9PSDdEMENiSkNqaHVFMVh5cmVNNFZYZzVKNml2UmtMZTRjci1ka0lnLXV6S2lFV3VTQ0RKLQ?oc=5", "source_name": "Cantech Letter", "published_at": "2023-04-11T07:00:00+00:00", "published_display": "11 Apr 2023 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Profound Medical (PROF) Stock Price, News & Analysis $PROF", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9iM2tXeEZJckJlZ2lpSjNMSC13ZVFNeG9FV0Jqa2tTVTU2cGxzZEhGZHFHNmk0eVRoc0o2LUlqNk1yX0EzRzNKZU5nU3d1aXdEME9aVXBxUzlKZw?oc=5", "source_name": "MarketBeat", "published_at": "2020-10-22T03:39:51+00:00", "published_display": "22 Oct 2020 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TULSA-PRO is looking like a winner for Profound Medical: Raymond James", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOV19XeXprX0xzb1NhTkJueGUzZGJOenRrWTNhaUxHbkxkV2lPbmtQX05YOElFVzYxN2VTSGFEYjhRRGlET1hQa1RYQWoyT25abGVReFppR3Nkb1FpTTFBNzY1UThIcnNDN0VXZjdkRU5WTHh6cEVTdG9jOWdsSWJLQ0lmNWY3c1NNNmdqSlJ6VFBKUm5UanNTc2dkM1FCNmNlZVZiaVl2YW9velVx0gGyAUFVX3lxTE8xQ1VXcnM5QmJ0TVd3WmpHbkVydjgwMXBuZWQwLVQyNU02U05vbldRaUtwNGNGY2NxX0FpdVNhRHBwdXBfTGFZb1BqbUdpS1VhVDlDZnN5V2twWFpwUGtxYmZNZXZMZTZLeVI0SFdaeTF0WUNQN2tGYWU0MG44WTBnbTRLYlRsWkdWUHFnTl9RRGdaSUNCN3JxbDdUZkpGaTRWT2E0OEo0YV9MdnB5YmF6enc?oc=5", "source_name": "Cantech Letter", "published_at": "2019-11-26T08:00:00+00:00", "published_display": "26 Nov 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Company Profile: Profound Medical", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5pMDlzMkxucUpncWQ5MkxwdXFRT0FuTVpvQlpEdmdRMXBwaVY1QXp5RjdpUFFFX09Gb280QjdXUTRsZ2FPNl9mbklxd2Z5MXFycWNzYTVKblBKaFNJY0QxOFFzc2RzcnRvekNzV2F6a0drd3RtMk80eA?oc=5", "source_name": "Focused Ultrasound Foundation", "published_at": "2018-03-21T07:00:00+00:00", "published_display": "21 Mar 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 95, "total_relevant": 60, "sentiment_summary": {"positive": 21, "negative": 2, "neutral": 37, "score": 57, "total": 60, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 17.95, "count": 32}, {"event": "earnings", "label": "Earnings", "weight": 13.2, "count": 24}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 21, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 7.04, "latest_week": "2026-07-10", "one_week_move": 3.4, "four_week_move": 6.3, "twelve_week_move": 5.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.355533, "market_dynamics_buy_signal": false, "relative_strength": -3.605532, "fair_value_gap": -5.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 43.4738, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.4% over one week, +6.3% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 20}, {"label": "TradingView", "count": 5}, {"label": "Stock Titan", "count": 5}, {"label": "Stock Traders Daily", "count": 4}, {"label": "TradingKey", "count": 3}, {"label": "Simply Wall Street", "count": 3}, {"label": "Investing News Network", "count": 3}, {"label": "dars.gov.et", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 60}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 32}, {"label": "Earnings", "count": 24}, {"label": "Guidance", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "60", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.4% over one week, +6.3% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Profound Medical Corp."}], "updated_at": "2026-07-16T14:28:22.464961+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}